IBA: IBA introduces QUASAR GRID3D Advantage Image Distortion Analysis System at ESTRO 2025 Congress
IBA (Ion Beam Applications S.A.), the world leader in particle accelerator technology and a global leading provider of dosimetry and quality assurance (QA) solutions, announces the launch of its QUASAR GRID3D Advantage
Read full article »
IBA is a Belgium-based company that develops and commercializes medical devices and software solutions for the diagnosis and treatment of cancer by proton beam therapy.
Read more